Carroll Financial Associates’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$4K Buy
+330
New +$4.67K ﹤0.01% 1392
2019
Q3
Sell
-3
Closed 1678
2019
Q2
$0 Buy
+3
New +$58 ﹤0.01% 1691
2019
Q1
Sell
-57
Closed -$1K 1478
2018
Q4
$1K Sell
57
-275
-83% -$5.54K ﹤0.01% 1248
2018
Q3
$7K Buy
332
+11
+3% +$249 ﹤0.01% 1001
2018
Q2
$6K Hold
321
﹤0.01% 1010
2018
Q1
$5K Buy
321
+154
+92% +$2.71K ﹤0.01% 1038
2017
Q4
$3K Buy
167
+105
+169% +$2.09K ﹤0.01% 1098
2017
Q3
$1K Buy
+62
New +$1.4K ﹤0.01% 1167

Other funds holding SBRA

Carroll Financial Associates's SBRA Position: Q4 2021 in Review

Carroll Financial Associates opened a new position in Sabra Healthcare REIT (SBRA) in Q4 2021: 330 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #1392 among its holdings. This is a return to the name: Carroll Financial Associates previously reported a position in SBRA as recently as Q2 2019.

Carroll Financial Associates first reported a position in SBRA in Q3 2017 and has held it in 8 quarters since. The position peaked at $7K in Q3 2018. 337 funds tracked by Wall St. Rank hold SBRA as of Q4 2021.

  • Carroll Financial Associates held 330 shares of Sabra Healthcare REIT worth $4K as of Q4 2021.
  • Sabra Healthcare REIT was a new Carroll Financial Associates position in Q4 2021.
  • Sabra Healthcare REIT made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1392 holding.
  • Carroll Financial Associates first reported a position in Sabra Healthcare REIT in Q3 2017 and has held it in 8 quarters since.
  • Carroll Financial Associates's Sabra Healthcare REIT position peaked at $7K in Q3 2018.
  • 337 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.